Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Letter to the Editor

Free Access

Repeated Lumbar Punctures for Non-Clinical Indications: How Do Patients Feel?

Alamri Y.a-c · MacAskill M.a, c · Anderson T.a-c

Author affiliations

aNew Zealand Brain Research Institute, bCanterbury District Health Board, and cDepartment of Medicine, University of Otago, Christchurch, New Zealand

Corresponding Author

Dr. Yassar Alamri

New Zealand Brain Research Institute

66 Stewart Street

Central Christchurch 8011 (New Zealand)

E-Mail yassar.alamri@nzbri.org

Related Articles for ""

Eur Neurol 2016;76:123-124

Dear Sir,

We read with interest the findings by Moisset et al. [1], especially data pertaining to indications for lumbar punctures (LPs). LP is a routine, albeit invasive, procedure used for diagnostic and research purposes [2]. The procedure is generally safe and most adverse effects are relatively minor [2]. Understandably however, anxiety about the procedure is often experienced by both patients and their caregivers [2]. In fact, 40.8% of patients in one study had worries about procedural complications and 16.1% had a reluctant attitude towards LPs [3].

Studies to date on pre-LP anxiety have either utilised invalidated anxiety measures or investigated anxiety after the procedure has been completed [2,4]. In a study that evaluated anxiety before as well as after LP, scores were generally higher before the procedure [4].

We conducted an open trial on blackcurrant antioxidant supplementation in Parkinson's disease (PD) patients. The study involved a small number (n = 10) of patients who took oral supplements for 28 days. To determine cerebrospinal fluid concentrations, patients received 2 LPs: at the start of the trial and after completing the treatment course. No specific additional monitoring was provided in the intervening period.

Prior to each LP, the patient's vital signs were recorded and they were administered the Hospital Anxiety and Depression Scale (HADS). The maximum score on each of the anxiety and depression sub-scales is 21; a cut-off of ≥8 suggests moderate anxiety or depression [5]. The HADS has been validated as an assessment instrument of anxiety and depression in the acute setting [6]. Our study, therefore, was uniquely poised to evaluate LP-associated anxiety prior to the procedure as well as the effect of repeated LPs on anxiety levels.

We observed a significant reduction on the HADS anxiety-subscale scores prior to the first LP (5.4 ± 3.6) compared with the second (2.5 ± 1.8), (t9 = 2.69, p = 0.025). A reduction on the depression sub-scale scores was not significant (4.1 vs. 2.9, p = 0.074). We found no significant differences in the patients' pre-LP vital signs between the 2 visits: systolic blood pressure (136 vs. 141 mm Hg, p = 0.61), diastolic blood pressure (77 vs. 82 mm Hg, p = 0.25) or heart rate (75 vs. 68 bpm, p = 0.28). Scores of neuropsychological assessments (including the Mini-Mental State Examination, Montreal Cognitive Assessment and unified PD rating scale) were also similar between the 2 visits.

These findings indicate that patients were less anxious prior to the second LP. Since blackcurrant antioxidants do not have any known anxiolytic effect this is unlikely to explain our findings. Similarly, the lack of difference on neuropsychological performance (including self-scores on mood) makes the observed decrease on the HADS anxiety sub-scale less likely to be due to a placebo effect.

We hypothesise that repeated explanation and reassurance by the physician performing the procedure as well as having had a successful first LP may have provided a necessary calming effect. A similar effect has been demonstrated in women undergoing hysterectomy who reported less anxiety if an information booklet was provided pre-operatively [7]. Our findings reiterate the safety of research LP and the importance of adequate consultation with patients prior to invasive procedures.

Acknowledgements

The authors would like to acknowledge Dr. Andrew Laurenson and Dr. Oliver Menzies for performing the LPs.

Statement of Ethics

This study was approved by Upper South A Regional Ethics Committee, reference: URA/10/03/022. Informed consent was obtained from all patients.

Disclosure Statement

The authors declare no conflict of interest. The trial was funded by Just The Berries, Ltd., New Zealand.


References

  1. Moisset X, Ruet A, Brochet B, Planche V, Jaffeux P, Gilleron V, Ong N, Clavelou P: Who performs lumbar puncture, how many do they perform, how and why? A retrospective study of 6,594 cases. Eur Neurol 2016;76:8-11.
  2. Peskind ER, Riekse R, Quinn JF, Kaye J, Clark CM, Farlow MR, et al: Safety and acceptability of the research lumbar puncture. Alzheimer Dis Assoc Disord 2005;19:220-225.
  3. Duits FH, Martinez-Lage P, Paquet C, Engelborghs S, Lleó A, Hausner L, et al: Performance and complications of lumbar puncture in memory clinics: results of the multicenter lumbar puncture feasibility study. Alzheimers Dement 2016;12:154-163.
  4. Nguyen TN, Nilsson S, Hellström AL, Bengtson A: Music therapy to reduce pain and anxiety in children with cancer undergoing lumbar puncture: a randomized clinical trial. J Pediatr Oncol Nurs 2010;27:146-155.
  5. Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res 2002;52:69-77.
  6. Turk DC, Dworkin RH, Trudeau JJ, Benson C, Biondi DM, Katz NP, et al: Validation of the hospital anxiety and depression scale in patients with acute low back pain. J Pain 2015;16:1012-1021.
  7. Denney MK, Williamson D, Penn R: Community medicine. Informed consent. Emotional responses of patients. Postgrad Med 1976;60:205-209.

Author Contacts

Dr. Yassar Alamri

New Zealand Brain Research Institute

66 Stewart Street

Central Christchurch 8011 (New Zealand)

E-Mail yassar.alamri@nzbri.org


Article / Publication Details

Received: August 10, 2016
Accepted: August 10, 2016
Published online: August 25, 2016
Issue release date: October 2016

Number of Print Pages: 2
Number of Figures: 0
Number of Tables: 0

ISSN: 0014-3022 (Print)
eISSN: 1421-9913 (Online)

For additional information: http://www.karger.com/ENE


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Moisset X, Ruet A, Brochet B, Planche V, Jaffeux P, Gilleron V, Ong N, Clavelou P: Who performs lumbar puncture, how many do they perform, how and why? A retrospective study of 6,594 cases. Eur Neurol 2016;76:8-11.
  2. Peskind ER, Riekse R, Quinn JF, Kaye J, Clark CM, Farlow MR, et al: Safety and acceptability of the research lumbar puncture. Alzheimer Dis Assoc Disord 2005;19:220-225.
  3. Duits FH, Martinez-Lage P, Paquet C, Engelborghs S, Lleó A, Hausner L, et al: Performance and complications of lumbar puncture in memory clinics: results of the multicenter lumbar puncture feasibility study. Alzheimers Dement 2016;12:154-163.
  4. Nguyen TN, Nilsson S, Hellström AL, Bengtson A: Music therapy to reduce pain and anxiety in children with cancer undergoing lumbar puncture: a randomized clinical trial. J Pediatr Oncol Nurs 2010;27:146-155.
  5. Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res 2002;52:69-77.
  6. Turk DC, Dworkin RH, Trudeau JJ, Benson C, Biondi DM, Katz NP, et al: Validation of the hospital anxiety and depression scale in patients with acute low back pain. J Pain 2015;16:1012-1021.
  7. Denney MK, Williamson D, Penn R: Community medicine. Informed consent. Emotional responses of patients. Postgrad Med 1976;60:205-209.
Figures

Tables